Long-term and quality of survival in patients treated for acute lymphoblastic leukemia during the pediatric age

Long-term survival for acute lymphoblastic leukemia (ALL) in children improved over the last three decades up to 80-90% of affected patients. Consequently, the quality of life of survivors has become increasingly important. This study analyses the clinical features and outcome of 119 children with A...

Full description

Bibliographic Details
Main Authors: Lara Devilli, Chiara Garonzi, Rita Balter, Elisa Bonetti, Matteo Chinello, Ada Zaccaron, Virginia Vitale, Massimiliano De Bortoli, Giulia Caddeo, Valentina Baretta, Gloria Tridello, Simone Cesaro
Format: Article
Language:English
Published: MDPI AG 2021-03-01
Series:Hematology Reports
Subjects:
Online Access:https://www.pagepress.org/journals/index.php/hr/article/view/8847
_version_ 1797935718948929536
author Lara Devilli
Chiara Garonzi
Rita Balter
Elisa Bonetti
Matteo Chinello
Ada Zaccaron
Virginia Vitale
Massimiliano De Bortoli
Giulia Caddeo
Valentina Baretta
Gloria Tridello
Simone Cesaro
author_facet Lara Devilli
Chiara Garonzi
Rita Balter
Elisa Bonetti
Matteo Chinello
Ada Zaccaron
Virginia Vitale
Massimiliano De Bortoli
Giulia Caddeo
Valentina Baretta
Gloria Tridello
Simone Cesaro
author_sort Lara Devilli
collection DOAJ
description Long-term survival for acute lymphoblastic leukemia (ALL) in children improved over the last three decades up to 80-90% of affected patients. Consequently, the quality of life of survivors has become increasingly important. This study analyses the clinical features and outcome of 119 children with ALL, focusing on the quality of long-term survival in a subset of 22 patients over 18 years of age. Among this group, the 10-year event-free survival and overall survival were 83.1% (C.I. 74.0-89.2) and 88.4% (C.I. 80.9-93.1), respectively. Treatment related long-term medical complications were reported only in 2 patients (9.1%). Secondary school was completed successfully in 20 of 22 patients (89.9%). The remaining 2 patients were still attending at the time of the analysis. In conclusion, current treatment for ALL is well tolerated and does not compromise significantly the quality of life of survivors.
first_indexed 2024-04-10T18:18:32Z
format Article
id doaj.art-eb66522ef8e247deb2bbc6600a4e4aaa
institution Directory Open Access Journal
issn 2038-8322
2038-8330
language English
last_indexed 2024-04-10T18:18:32Z
publishDate 2021-03-01
publisher MDPI AG
record_format Article
series Hematology Reports
spelling doaj.art-eb66522ef8e247deb2bbc6600a4e4aaa2023-02-02T08:06:43ZengMDPI AGHematology Reports2038-83222038-83302021-03-0113110.4081/hr.2021.8847Long-term and quality of survival in patients treated for acute lymphoblastic leukemia during the pediatric ageLara Devilli0Chiara Garonzi1Rita Balter2Elisa Bonetti3Matteo Chinello4Ada Zaccaron5Virginia Vitale6Massimiliano De Bortoli7Giulia Caddeo8Valentina Baretta9Gloria Tridello10Simone Cesaro11Pediatric Hematology Oncology, Department of Mother and Child, Azienda Ospedaliera Universitaria Integrata, VeronaPediatric Hematology Oncology, Department of Mother and Child, Azienda Ospedaliera Universitaria Integrata, VeronaPediatric Hematology Oncology, Department of Mother and Child, Azienda Ospedaliera Universitaria Integrata, VeronaPediatric Hematology Oncology, Department of Mother and Child, Azienda Ospedaliera Universitaria Integrata, VeronaPediatric Hematology Oncology, Department of Mother and Child, Azienda Ospedaliera Universitaria Integrata, VeronaPediatric Hematology Oncology, Department of Mother and Child, Azienda Ospedaliera Universitaria Integrata, VeronaPediatric Hematology Oncology, Department of Mother and Child, Azienda Ospedaliera Universitaria Integrata, VeronaPediatric Hematology Oncology, Department of Mother and Child, Azienda Ospedaliera Universitaria Integrata, VeronaPediatric Hematology Oncology, Department of Mother and Child, Azienda Ospedaliera Universitaria Integrata, VeronaPediatric Hematology Oncology, Department of Mother and Child, Azienda Ospedaliera Universitaria Integrata, VeronaPediatric Hematology Oncology, Department of Mother and Child, Azienda Ospedaliera Universitaria Integrata, VeronaPediatric Hematology Oncology, Department of Mother and Child, Azienda Ospedaliera Universitaria Integrata, VeronaLong-term survival for acute lymphoblastic leukemia (ALL) in children improved over the last three decades up to 80-90% of affected patients. Consequently, the quality of life of survivors has become increasingly important. This study analyses the clinical features and outcome of 119 children with ALL, focusing on the quality of long-term survival in a subset of 22 patients over 18 years of age. Among this group, the 10-year event-free survival and overall survival were 83.1% (C.I. 74.0-89.2) and 88.4% (C.I. 80.9-93.1), respectively. Treatment related long-term medical complications were reported only in 2 patients (9.1%). Secondary school was completed successfully in 20 of 22 patients (89.9%). The remaining 2 patients were still attending at the time of the analysis. In conclusion, current treatment for ALL is well tolerated and does not compromise significantly the quality of life of survivors.https://www.pagepress.org/journals/index.php/hr/article/view/8847acute lymphoblastic leukemiapediatric leukemiasurvival
spellingShingle Lara Devilli
Chiara Garonzi
Rita Balter
Elisa Bonetti
Matteo Chinello
Ada Zaccaron
Virginia Vitale
Massimiliano De Bortoli
Giulia Caddeo
Valentina Baretta
Gloria Tridello
Simone Cesaro
Long-term and quality of survival in patients treated for acute lymphoblastic leukemia during the pediatric age
Hematology Reports
acute lymphoblastic leukemia
pediatric leukemia
survival
title Long-term and quality of survival in patients treated for acute lymphoblastic leukemia during the pediatric age
title_full Long-term and quality of survival in patients treated for acute lymphoblastic leukemia during the pediatric age
title_fullStr Long-term and quality of survival in patients treated for acute lymphoblastic leukemia during the pediatric age
title_full_unstemmed Long-term and quality of survival in patients treated for acute lymphoblastic leukemia during the pediatric age
title_short Long-term and quality of survival in patients treated for acute lymphoblastic leukemia during the pediatric age
title_sort long term and quality of survival in patients treated for acute lymphoblastic leukemia during the pediatric age
topic acute lymphoblastic leukemia
pediatric leukemia
survival
url https://www.pagepress.org/journals/index.php/hr/article/view/8847
work_keys_str_mv AT laradevilli longtermandqualityofsurvivalinpatientstreatedforacutelymphoblasticleukemiaduringthepediatricage
AT chiaragaronzi longtermandqualityofsurvivalinpatientstreatedforacutelymphoblasticleukemiaduringthepediatricage
AT ritabalter longtermandqualityofsurvivalinpatientstreatedforacutelymphoblasticleukemiaduringthepediatricage
AT elisabonetti longtermandqualityofsurvivalinpatientstreatedforacutelymphoblasticleukemiaduringthepediatricage
AT matteochinello longtermandqualityofsurvivalinpatientstreatedforacutelymphoblasticleukemiaduringthepediatricage
AT adazaccaron longtermandqualityofsurvivalinpatientstreatedforacutelymphoblasticleukemiaduringthepediatricage
AT virginiavitale longtermandqualityofsurvivalinpatientstreatedforacutelymphoblasticleukemiaduringthepediatricage
AT massimilianodebortoli longtermandqualityofsurvivalinpatientstreatedforacutelymphoblasticleukemiaduringthepediatricage
AT giuliacaddeo longtermandqualityofsurvivalinpatientstreatedforacutelymphoblasticleukemiaduringthepediatricage
AT valentinabaretta longtermandqualityofsurvivalinpatientstreatedforacutelymphoblasticleukemiaduringthepediatricage
AT gloriatridello longtermandqualityofsurvivalinpatientstreatedforacutelymphoblasticleukemiaduringthepediatricage
AT simonecesaro longtermandqualityofsurvivalinpatientstreatedforacutelymphoblasticleukemiaduringthepediatricage